Showing results (241-250 of 247) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Endocrine Journal|March 31, 2015
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetesHae Kyung Yang, Kyung Wan Min, Sung Woo Park, et al.Yonsei Medical Journal|April 11, 2014
Efficacy and safety of weekly alendronate plus vitamin D₃ 5600 IU versus weekly alendronate alone in Korean osteoporotic women: 16-week randomized trialKwang Joon Kim, Yong-Ki Min, Jung-Min Koh, et al.Diabetes & Metabolism Journal|January 4, 2019
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled TrialTae Jung Oh, Jae Myung Yu, Kyung Wan Min, et al.Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.Diabetes & Metabolism Journal|August 15, 2020
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational StudyJun Sung Moon, Sunghwan Suh, Sang Soo Kim, et al.Journal of Bone and Mineral Metabolism|September 22, 2018
Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in KoreaDong Won Byun, Seong-Hwan Moon, Tak Kim, et al.Diabetes & Metabolism Journal|May 19, 2024
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled TrialJie-Eun Lee, Seung Hee Yu, Sung Rae Kim, et al.Pageof 25